Mater Specialist Quick Find


Shortage of intravenous Benzylpenicillin

Tuesday 20 August 2019

Shortage of intravenous Benzylpenicillin

There is currently an Australian-wide shortage of intravenous Benzylpenicillin. Supply of stock is anticipated to be constrained at least until January 2020.

Mater has put in place measure to secure stock of IV Benzylpenicillin. However, in order to ensure that patients who are most in need of his antimicrobial agent are able to receive it, we ask for your co-operation and support please with the measures outlined below.

As per Australian Therapeutic Guidelines, conserve the use of IV Benzylpenicillin for the following indications:

  1. Neurosyphilis
  2. Congenital syphilis

For all other indications please refer to the guidelines below for empiric regimes for alternatives to Benzylpenicillin.

If Benzylpenicillin is still recommended for the indication, consult with Infectious Diseases physician on-call via Mater switchboard (8111).


Archived news

View our online archive news articles.

  • Mater Health Centres

    Providing local communities with access to integrated health care & services.

    Read more

  • Professional Development

    GP Education, Maternity Shared Care Alignment Program and Events.

    Read more

  • Featured Event

    Join us for a GP Education night covering Orthopaedics, General Medicine and Urology on 11 March 2020 at Quest Springfield Central

    Read more